Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negative interim PET after 2 chemotherapy cycles- RAFTING
Immunotherapy with dinutuximab beta in combination with chemotherapy for the treatment of patients with primary neuroblastoma refractory to standard therapy and with relapsed or progressive disease
The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endothelial function in patients undergoing endovascular treatment due to peripheral arterial disease
Independent Randomized Clinical Trial in Carotid Revascularization with MicroNet Covered Stent (CGuard) Comparing Early Neurological Outcomes with distal EPS Versus Proximal EPS. The SIBERIA II Trial
Optimal Antiplatelet Treatment to Achieve Stroke Avoidance and Fall in Bleeding Events following Left Atrial Appendage Closure – Chronic Kidney Disease (SAFE LAAC CKD). Comparative Health Effectiveness Ancillary Study – PILOT
Sacubitril/valsartan in preventing disease progression in patients with arrhythmogenic right ventricular cardiomyopathy - the ARNI-ARVC multi-site randomized trial
Multicenter Polish Study of the Use of Bromocriptine in Perinatal Cardiomyopathy. New BioMarkers in the Early Diagnosis of Peripartum CardioMyopathy. PolBrom-PPCM
A randomized, ongoing, open clinical trial evaluating the anti-atherosclerotic efficacy of selected antidiabetic medications in patients with coronary artery disease and pre-diabetic conditions.
